Search

Simple Summary: Risk assessment in early breast cancer is critical for clinical decisions, but defining risk categories poses a significant challenge. The integration of conventional histopathology and biomarkers with artificial intelligence (AI) techniques, including machine learning and deep learning, has the potential to offer more precise information. AI applications extend beyond detection to histological subtyping, grading, and molecular feature identification. The successful integration of AI into clinical practice requires collaboration between histopathologists, molecular pathologists, computational pathologists, and oncologists to optimize patient outcomes. Effective risk assessment in early breast cancer is essential for informed clinical decision-making, yet consensus on defining risk categories remains challenging. This paper explores evolving approaches in risk stratification, encompassing histopathological, immunohistochemical, and molecular biomarkers alongside cutting-edge artificial intelligence (AI) techniques. Leveraging machine learning, deep learning, and convolutional neural networks, AI is reshaping predictive algorithms for recurrence risk, thereby revolutionizing diagnostic accuracy and treatment planning. Beyond detection, AI applications extend to histological subtyping, grading, lymph node assessment, and molecular feature identification, fostering personalized therapy decisions. With rising cancer rates, it is crucial to implement AI to accelerate breakthroughs in clinical practice, benefiting both patients and healthcare providers. However, it is important to recognize that while AI offers powerful automation and analysis tools, it lacks the nuanced understanding, clinical context, and ethical considerations inherent to human pathologists in patient care. Hence, the successful integration of AI into clinical practice demands collaborative efforts between medical experts and computational pathologists to optimize patient outcomes. [ABSTRACT FROM AUTHOR]

Artificial intelligence (AI) algorithms are playing a crucial role in transforming healthcare by enhancing the quality, accessibility, and efficiency of medical care, research, and operations. These algorithms enable healthcare providers to offer more accurate diagnoses, predict outcomes, and customize treatments to individual patient needs. AI also improves operational efficiency by automating routine tasks and optimizing resource management. However, there are challenges to adopting AI in healthcare, such as data privacy concerns and potential biases in algorithms. Collaboration among stakeholders is necessary to ensure ethical use of AI and its positive impact on the field. AI also has applications in medical research, preventive medicine, and public health. It is important to recognize that AI should augment, not replace, the expertise and compassionate care provided by healthcare professionals. The ethical implications and societal impact of AI in healthcare must be carefully considered, guided by fairness, transparency, and accountability principles. Several research papers in this special issue explore the application of AI algorithms in various aspects of healthcare, such as gait analysis for Parkinson's disease diagnosis, human activity recognition, heart disease prediction, compliance assessment with clinical protocols, epidemic management, neurological complications identification, fall prevention, leukemia diagnosis, and genetic clinical pathways. These studies demonstrate the potential of AI in improving medical diagnostics, patient monitoring, and personalized care. [Extracted from the article]